Connect with us

Foreign

BioNTech to establish mRNA lab in Australia

Published

on

 German pharmaceutical firm and vaccine maker BioNTech on Friday said it had agreed in principle to establish an mRNA manufacturing facility in Melbourne The company said it would work with government in the Australian state of Melbourne to collaborate on the research and development of potential mRNA based vaccines and therapies Messenger ribonucleic acid mRNA technology has already been employed successfully in BioNTech s coronavirus vaccine the German company said in a statement BioNTech plans to set up a clinical scale end to end mRNA manufacturing facility based on its BioNTainer solution in Melbourne with the aim of supporting the design manufacture and clinical testing of product candidates BioNTech said it also plans to expand its clinical development capabilities in Australia and evaluate the testing of additional therapeutic options for cancer This partnership is a major step forward to enable access to mRNA technology and promote collaborations in the Asia Pacific region said BioNTech boss Ugur Sahin Australia provides excellent academic research and we are looking forward to collaborating with world class scientists and researchers to strengthen Australia s mRNA ecosystem and to jointly develop potential novel treatments and vaccines for people worldwide According to the company its oncology pipeline currently comprises 18 product candidates in 23 ongoing clinical trials NewsSourceCredit NAN
BioNTech to establish mRNA lab in Australia

German pharmaceutical firm and vaccine maker BioNTech on Friday said it had agreed in principle to establish an mRNA manufacturing facility in Melbourne.

shopify blogger outreach legit nigerian news

The company said it would work with government in the Australian state of Melbourne to collaborate “on the research and development of potential mRNA-based vaccines and therapies.

legit nigerian news

Messenger ribonucleic acid (mRNA) technology has already been employed successfully in BioNTech’s coronavirus vaccine, the German company said in a statement.

legit nigerian news

“BioNTech plans to set up a clinical scale end-to-end mRNA manufacturing facility based on its BioNTainer solution in Melbourne with the aim of supporting the design, manufacture and clinical testing of product candidates.

BioNTech said it also plans to expand its clinical development capabilities in Australia and evaluate the testing of additional therapeutic options for cancer.

Ugur Sahin

“This partnership is a major step forward to enable access to mRNA technology and promote collaborations in the Asia-Pacific region,” said BioNTech boss Ugur Sahin.

“Australia provides excellent academic research, and we are looking forward to collaborating with world-class scientists and researchers to strengthen Australia’s mRNA ecosystem and to jointly develop potential novel treatments and vaccines for people worldwide.

According to the company, its oncology pipeline currently comprises 18 product candidates in 23 ongoing clinical trials.

NewsSourceCredit: NAN

bet shop 9ja alfijir hausa name shortner downloader for tiktok

NNN is an online Nigerian news portal that publishes breaking news in Nigeria and the world.Contacti: editor @ nnn.ng. Disclaimer.